TOTALMED INC. NAMES JUSTIN TOMLIN CHIEF STRATEGY OFFICER

APPLETON, Wis., June 2, 2023 /PRNewswire/ — TotalMed Inc. announced that the company has appointed Justin Tomlin as its first Chief Strategy Officer to join the company’s executive leadership team. In his new role, Tomlin is responsible for enterprise strategy, workforce technology solutions and customer innovation & experience. TOTALMED INC. NAMES JUSTIN TOMLIN CHIEF STRATEGY OFFICER … Read more

Geisinger Health Plan ranked best commercial health plan in Pennsylvania by J.D. Power for fourth year in a row

DANVILLE, Pa., June 2, 2023 /PRNewswire/ — For the fourth year in a row, Geisinger Health Plan (GHP) ranked best among commercial health plans in Pennsylvania for member satisfaction in the J.D. Power 2023 U.S. Commercial Member Health Plan Study. The study examines several key factors. GHP ranked No. 1 in cost, coverage and benefits, customer service, … Read more

Advancing Shared Decision-Making in Precision Medicine

CHICAGO, June 2, 2023 /PRNewswire/ — AESOP Technology, in collaboration with AstraZeneca Taiwan, has unveiled Medigator, an innovative AI software designed to manage immune-related adverse events (irAEs) and enhance the effectiveness of immunotherapy. With cancer being the second leading cause of death and immunotherapy offering improved survival rates, Medigator is specially designed to address the … Read more

Indivior Reaches Agreement with States’ Attorneys General and District of Columbia to Resolve Antitrust Multi-District Litigation Claims

RICHMOND, Va., June 2, 2023 /PRNewswire/ — Indivior PLC (LSE: INDV), a leading addiction treatment company, announced that its subsidiary, Indivior Inc. (the “Company”), has reached an agreement to resolve the claims brought by the Attorneys General of 41 states and the District of Columbia (“the Claimants”) in the In re Suboxone Antitrust Litigation multi-district litigation (“MDL”). … Read more

Indivior Reaches Agreement with States’ Attorneys General and District of Columbia to Resolve Antitrust Multi-District Litigation Claims

RICHMOND, Va., June 2, 2023 /PRNewswire/ — Indivior PLC (LSE: INDV), a leading addiction treatment company, announced that its subsidiary, Indivior Inc. (the “Company”), has reached an agreement to resolve the claims brought by the Attorneys General of 41 states and the District of Columbia (“the Claimants”) in the In re Suboxone Antitrust Litigation multi-district … Read more

Enzo Biochem Confirms Data Breach Leaked 600k Social Security Numbers and the Confidential Test Results of Nearly 2.5 Million Patients

MARLTON, N.J., June 2, 2023 /PRNewswire/ — Approximately 2.5 million people across the United States are being notified that their protected health information and Social Security numbers were compromised when hackers breached the computer system of Enzo Biochem, Inc. earlier this year. The data breach lawyers at Console & Associates, P.C. are investigating claims on … Read more

PatientRightsAdvocate.org Applauds Gov. Polis Signing Bipartisan Hospital Price Transparency Bill into Law

New law “a triumph for Colorado patients over secrecy and special interests” WASHINGTON, June 2, 2023 /PRNewswire/ — PatientRightsAdvocate.org (PRA) celebrated today’s signing of Senate Bill 252 by Colorado Governor Jared Polis at a public ceremony in Denver. The bipartisan legislation requires Colorado hospitals to comply with federal price transparency rules by posting all of their prices … Read more

Quest Diagnostics to Speak at the Jefferies Global Healthcare Conference

SECAUCUS, N.J., June 2, 2023 /PRNewswire/ — Quest Diagnostics Incorporated (NYSE: DGX), the world’s leading provider of diagnostic information services, announced that it is scheduled to speak at the Jefferies Global Healthcare Conference. Jim Davis, Chairman, CEO and President, will discuss recent market developments and trends as well as the company’s performance and strategy. The … Read more

CURE HOSTS “AI FOR GOOD” SUPER SESSION TO MAKE SENSE OF BIG DATA AND HIGH TECH AT 2023 BIO INTERNATIONAL CONVENTION ON JUNE 5

Cure CEO Seema Kumar to Announce BioGENEius Award Winner at BIO Opening Plenary and participate in Women In Bio Plenary June 5 Cure to Showcase Cure Innovation Labs, CureXChange Collaboration Residency and Cure Studio on the Road at BIO Exhibit NEW YORK, June 2, 2023 /PRNewswire/ — Cure®, a healthcare innovation campus in New York City, … Read more

IVBH Presents Groundbreaking Data for Early Lung Cancer Detection at the ASCO® 2023 Annual Meeting

IVBH’s novel RNA approach to early detection demonstrates strong sensitivity and specificity for early lung cancer detection, in a large, predominantly early-stage, independent validation cohort NEWPORT BEACH, Calif., June 2, 2023 /PRNewswire/ — IVBH, a leader in liquid biopsy technology, specializing in noninvasive early detection, will unveil groundbreaking data from an independent validation study of the … Read more